Your browser doesn't support javascript.
loading
PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma.
Mondal, Isha; Das, Oishika; Sun, Raymond; Gao, Jian; Yu, Bohyeon; Diaz, Aaron; Behnan, Jinan; Dubey, Abhishek; Meng, Zhipeng; Eskandar, Emad; Xu, Beisi; Lu, Rongze Olivia; Ho, Winson S.
Afiliación
  • Mondal I; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California.
  • Das O; Department of Neurosurgery, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Sun R; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California.
  • Gao J; Department of Neurosurgery, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Yu B; Department of Neurosurgery, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Diaz A; Department of Neurosurgery, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Behnan J; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California.
  • Dubey A; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California.
  • Meng Z; The Leo M. Davidoff Department of Neurological Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Eskandar E; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York.
  • Xu B; Dominick Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York.
  • Lu RO; The Leo M. Davidoff Department of Neurological Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Ho WS; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York.
Cancer Res ; 83(15): 2527-2542, 2023 08 01.
Article en En | MEDLINE | ID: mdl-37219874

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Glioblastoma / Glioma Límite: Humans Idioma: En Revista: Cancer Res Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Glioblastoma / Glioma Límite: Humans Idioma: En Revista: Cancer Res Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos